Enfusion Q2 EPS $0.01 Misses $0.05 Estimate, Sales $42.72M Miss $44.58M Estimate
Portfolio Pulse from saritha@benzinga.com
Enfusion (NYSE:ENFN) reported Q2 earnings of $0.01 per share, missing the analyst consensus estimate of $0.05 by 80%. The company also reported quarterly sales of $42.72 million, missing the analyst consensus estimate of $44.58 million by 4.17%. However, this represents a 133.33% increase in earnings and a 16.92% increase in sales compared to the same period last year.
August 08, 2023 | 11:52 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Enfusion's Q2 earnings and sales missed analyst estimates, which could negatively impact the stock price in the short term. However, the YoY growth in earnings and sales may mitigate this impact.
Missing analyst estimates for both earnings and sales is typically seen as a negative signal by the market, which could lead to a short-term decrease in the stock price. However, the significant YoY growth in both earnings and sales may be seen as a positive signal, potentially mitigating the negative impact.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100